↓ Skip to main content

Development of a risk-adjustment model for antimicrobial utilization data in 21 public hospitals in Queensland, Australia (2006–11)

Overview of attention for article published in Journal of Antimicrobial Chemotherapy (JAC), May 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Development of a risk-adjustment model for antimicrobial utilization data in 21 public hospitals in Queensland, Australia (2006–11)
Published in
Journal of Antimicrobial Chemotherapy (JAC), May 2013
DOI 10.1093/jac/dkt175
Pubmed ID
Authors

M. Rajmokan, A. Morton, J. Marquess, E. G. Playford, M. Jones

Abstract

Making valid comparisons of antimicrobial utilization between hospitals requires risk adjustment for each hospital's case mix. Data on individual patients may be unavailable or difficult to process. Therefore, risk adjustment for antimicrobial usage frequently needs to be based on a hospital's services. This study evaluated such a strategy for hospital antimicrobial utilization.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Denmark 1 2%
Australia 1 2%
Unknown 38 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 20%
Student > Master 6 15%
Student > Ph. D. Student 6 15%
Other 4 10%
Student > Postgraduate 3 7%
Other 6 15%
Unknown 8 20%
Readers by discipline Count As %
Medicine and Dentistry 15 37%
Pharmacology, Toxicology and Pharmaceutical Science 7 17%
Business, Management and Accounting 2 5%
Agricultural and Biological Sciences 2 5%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 4 10%
Unknown 10 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2013.
All research outputs
#14,278,325
of 25,374,917 outputs
Outputs from Journal of Antimicrobial Chemotherapy (JAC)
#5,282
of 8,174 outputs
Outputs of similar age
#107,446
of 209,044 outputs
Outputs of similar age from Journal of Antimicrobial Chemotherapy (JAC)
#46
of 109 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,174 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,044 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.